Bacon, W. A., Long, G. D., Rizzieri, D. A., Horwitz, M. E., Chute, J. P., Sullivan, K. M., … Gasparetto, C. (2011). Impact of High Dose Cyclophosphamide on the Outcome of Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma. In BLOOD (Vol. 118, pp. 1765–1765). San Diego, CA: AMER SOC HEMATOLOGY.

Bacon, Wendi A., Gwynn D. Long, David A. Rizzieri, Mitchell E. Horwitz, John P. Chute, Keith M. Sullivan, Amanda Yopp, Angela Johns, Nelson J. Chao, and Cristina Gasparetto. “Impact of High Dose Cyclophosphamide on the Outcome of Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma.” In BLOOD, 118:1765–1765. AMER SOC HEMATOLOGY, 2011.

Bacon WA, Long GD, Rizzieri DA, Horwitz ME, Chute JP, Sullivan KM, et al. Impact of High Dose Cyclophosphamide on the Outcome of Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma. In: BLOOD. AMER SOC HEMATOLOGY; 2011. p. 1765–1765.

Bacon, Wendi A., et al. “Impact of High Dose Cyclophosphamide on the Outcome of Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma.” BLOOD, vol. 118, no. 21, AMER SOC HEMATOLOGY, 2011, pp. 1765–1765.

Bacon WA, Long GD, Rizzieri DA, Horwitz ME, Chute JP, Sullivan KM, Yopp A, Johns A, Chao NJ, Gasparetto C. Impact of High Dose Cyclophosphamide on the Outcome of Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma. BLOOD. AMER SOC HEMATOLOGY; 2011. p. 1765–1765.